https://www.selleckchem.com/pr....oducts/midostaurin-p
The pooled estimate demonstrated non-significant differences between PRP and HA for clinical outcomes at 6 months (p = 0.069) and at 12 months (p = 0.188). However, the pooled estimate for pain did demonstrate significant differences in favour of PRP at 6 months (p = 0.001) and 12 months (p = 0.001). For the ACP subgroup (249 cases), the pooled estimate for these studies demonstrated significant differences in favour of PRP (p less then 0.0001) at 6 months. CONCLUSION The results of this systematic review and meta-analysis
Gefällt mir
Kommentar
Teilen
